Myomo, Inc.: First FDA Cleared Device to Non-Invasively Use a Person’s Electrical Muscle Activity to Automatically Control Movement of Partially Paralyzed Arms Impaired by Stroke

BOSTON, MA (July 10, 2007) -- Myomo,™ Inc. today announced that the company received U.S. Food and Drug Administration (FDA) 510(k) clearance to market the Myomo e100 NeuroRobotic™ System. Myomo's first product is a wearable, portable therapeutic modality designed to allow patients to self initiate and control movement of partially paralyzed limbs using their own biological signals. By simultaneously engaging and reinforcing both neurological and motor pathways, the device helps people relearn how to move affected muscles. No electrical stimulation or invasive procedures are employed.